FI942272L - Nomegestrolijohdannaisperustaiset ihonalaiset implantit - Google Patents

Nomegestrolijohdannaisperustaiset ihonalaiset implantit Download PDF

Info

Publication number
FI942272L
FI942272L FI942272A FI942272A FI942272L FI 942272 L FI942272 L FI 942272L FI 942272 A FI942272 A FI 942272A FI 942272 A FI942272 A FI 942272A FI 942272 L FI942272 L FI 942272L
Authority
FI
Finland
Prior art keywords
nomegestrol
derivative
subcutaneous implants
based subcutaneous
implants
Prior art date
Application number
FI942272A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI942272A0 (fi
FI942272A7 (fi
Inventor
Michel Lanquetin
Jean-Louis Thomas
Jacques Paris
Elsimar Coutinho
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of FI942272A0 publication Critical patent/FI942272A0/fi
Publication of FI942272L publication Critical patent/FI942272L/fi
Publication of FI942272A7 publication Critical patent/FI942272A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
FI942272A 1992-09-21 1993-09-17 Nomegestrolijohdannaisperustaiset ihonalaiset implantit FI942272A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
PCT/FR1993/000900 WO1994006437A1 (fr) 1992-09-21 1993-09-17 Implants sous-cutanes a base de derives de nomegestrol

Publications (3)

Publication Number Publication Date
FI942272A0 FI942272A0 (fi) 1994-05-16
FI942272L true FI942272L (fi) 1994-05-16
FI942272A7 FI942272A7 (fi) 1994-05-16

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942272A FI942272A7 (fi) 1992-09-21 1993-09-17 Nomegestrolijohdannaisperustaiset ihonalaiset implantit

Country Status (31)

Country Link
US (1) US5565443A (2)
EP (1) EP0613372B1 (2)
JP (1) JPH08506318A (2)
KR (1) KR100255700B1 (2)
CN (1) CN1095667C (2)
AP (1) AP497A (2)
AT (1) ATE198275T1 (2)
AU (1) AU683423B2 (2)
BG (1) BG62317B1 (2)
BR (1) BR9305642A (2)
CA (1) CA2122827A1 (2)
CZ (1) CZ284806B6 (2)
DE (1) DE69329790D1 (2)
DZ (1) DZ1717A1 (2)
EC (1) ECSP930986A (2)
FI (1) FI942272A7 (2)
FR (1) FR2695826B1 (2)
HU (1) HUT67044A (2)
IL (1) IL107039A (2)
MA (1) MA22978A1 (2)
NO (1) NO306238B1 (2)
OA (1) OA09924A (2)
PL (1) PL176120B1 (2)
RO (1) RO115783B1 (2)
RU (1) RU2120797C1 (2)
SK (1) SK54694A3 (2)
TN (1) TNSN93104A1 (2)
TW (1) TW381024B (2)
WO (1) WO1994006437A1 (2)
YU (1) YU60493A (2)
ZA (1) ZA936964B (2)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
GB2355728A (en) * 1999-10-27 2001-05-02 Anson Medical Ltd Tubular medical implants and methods of manufacture
ATE355854T1 (de) 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
MXPA04000156A (es) 2001-06-29 2005-06-06 Medgraft Microtech Inc Implantes inyectables biodegradables y metodos relacionados de fabricacion y uso.
CA2487577C (en) * 2002-05-31 2014-11-18 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
SI1610791T1 (sl) * 2003-03-31 2011-05-31 Titan Pharmaceuticals Inc Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista
MXPA05012768A (es) * 2003-05-30 2006-02-22 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para liberacion prolongada de nalmefeno.
DK1670433T3 (da) 2003-10-10 2012-03-12 Ferring Bv Transdermal farmaceutisk formulering til mindskelse af hudrester
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
FR2904213B1 (fr) * 2006-07-27 2008-10-10 Creaspine Soc Par Actions Simp Implant intervertebral destine a la fusion osseuse
ES2718612T3 (es) 2007-12-20 2019-07-03 Evonik Corp Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
US12582767B2 (en) 2021-12-30 2026-03-24 Taiyo Weber Compressible, minimally invasive implants and related systems and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
FI942272A0 (fi) 1994-05-16
TNSN93104A1 (fr) 1994-03-17
WO1994006437A1 (fr) 1994-03-31
AU683423B2 (en) 1997-11-13
ECSP930986A (es) 1994-04-12
CN1094284A (zh) 1994-11-02
AP497A (en) 1996-05-28
AP9300576A0 (2) 1993-10-31
FR2695826A1 (fr) 1994-03-25
CN1095667C (zh) 2002-12-11
BR9305642A (pt) 1996-01-09
IL107039A0 (en) 1993-12-28
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
PL176120B1 (pl) 1999-04-30
HU9401395D0 (en) 1994-08-29
FR2695826B1 (fr) 1995-01-06
YU60493A (sh) 1997-01-08
EP0613372A1 (fr) 1994-09-07
TW381024B (en) 2000-02-01
CZ116494A3 (en) 1995-03-15
CZ284806B6 (cs) 1999-03-17
CA2122827A1 (fr) 1994-03-31
DZ1717A1 (fr) 2002-02-17
OA09924A (fr) 1994-09-15
US5565443A (en) 1996-10-15
ZA936964B (en) 1994-04-14
ATE198275T1 (de) 2001-01-15
FI942272A7 (fi) 1994-05-16
SK54694A3 (en) 1994-10-05
BG98776A (bg) 1995-02-28
KR100255700B1 (ko) 2000-08-01
EP0613372B1 (fr) 2000-12-27
IL107039A (en) 1999-01-26
MA22978A1 (fr) 1994-04-01
RO115783B1 (ro) 2000-06-30
DE69329790D1 (de) 2001-02-01
NO941900D0 (no) 1994-05-20
HUT67044A (en) 1995-01-30
AU4822993A (en) 1994-04-12
BG62317B1 (bg) 1999-08-31
NO306238B1 (no) 1999-10-11
RU2120797C1 (ru) 1998-10-27

Similar Documents

Publication Publication Date Title
FI942272A7 (fi) Nomegestrolijohdannaisperustaiset ihonalaiset implantit
DE69329660D1 (de) IMPLANTIERBARE ANSATZSTüCKE
FI920305A7 (fi) Kirurginen implantti
DE69324036D1 (de) Dentales implantat
DE69223264D1 (de) Implantierbare leitung
FR2699413B1 (fr) Stimulateur cardiaque implantable.
DE69210380D1 (de) Implantierbarer Defibrillator
EP0836439A4 (en) VISIBLE AND PROGRAMMABLE SUBCUTANEOUS IMPLANT
DE4396657T1 (de) Gefäßprothese
DE68906516D1 (de) Implantat.
FI892255L (fi) Intraokulaert foerkammare-implantat.
DE69304996D1 (de) Herzschrittmacher
EE9600122A (et) Infuuser
DE59208828D1 (de) Implantierbarer Defibrillator
DE69126341D1 (de) Elektrotherapeutische Einrichtung
DE69328001D1 (de) Herzschrittmacher
FI933059L (fi) Biokompatibelt formbart polymermaterial
DE68909239D1 (de) Implantierbare Prothese.
DE69735754D1 (de) Impedanz-abhängiger implantierbarer kardiovertierer defribillator
DE69307754D1 (de) Gewebe
BR9307470A (pt) Implante
NO933216D0 (no) Implantat
FR2629338B1 (fr) Implant femoro-rotulien
DK0695159T3 (da) Patientløfteaggregat
FI971752A0 (fi) Ihonalaisesti annettava valmiste